Background
Methods
Setting
Sample size
Selection procedure
Data collection
Wish to die
Other covariates
Ethical statement
Statistical analysis
Results
Participants
Prevalence of the wish to die
Determinants of the wish to die
Total sample | No wish to die | Wish to die | P-value | |
---|---|---|---|---|
Sample size | 232 | 212 | 20 | |
Age, mean (SD), years | 79.3 (8.1) | 78.9 (8.2) | 83.6 (6.4) | .014 |
Women, % | 44.8 | 44.8 | 45.0 | .987 |
CASP-12, mean (SD) | 26.1 (5.3) | 26.5 (5.1) | 21.4 (5.3) | <.001 |
QoL - Single question, mean (SD) | 6.9 (1.8) | 7.1 (1.6) | 4.8 (2.6) | <.001a |
MOS-SSS, mean (SD) | 73.6 (15.6) | 74.0 (15.7) | 69.2 (14.1) | .114a |
CES-D, mean (SD) | 12.5 (6.7) | 12.2 (6.5) | 16.0 (7.8) | .044a |
Adapted SPIR, mean (SD) | 5.9 (3.2) | 5.9 (3.3) | 5.7 (2.7) | .619a |
Charlson score, mean (SD) | 5.9 (11.0) | 5.3 (8.1) | 12.7 (26.3) | .447a |
Number of medications, mean (SD) | 7.4 (3.8) | 7.5 (3.9) | 5.9 (3.4) | .067a |
Functional status, mean (SD) | 6.3 (1.3) | 6.3 (1.3) | 6.2 (1.3) | .805 |
DNR order, % | 71.4 | 69.8 | 88.2 | .108 |
Model 1 | P-value | Model 2 | P-value | |
---|---|---|---|---|
Age (per 5-year increase) | – | 1.43 (1.00–2.04) | .048 | |
CASP-12 (per 5-point increase) | 0.41 (0.26–0.66) | <.001 | 0.84 (0.44–1.60) | .599 |
QoL - Single question | 0.54 (0.41–0.70) | <.001 | 0.54 (0.39–0.75) | <.001 |
CES-D (per 2-point increase) | 1.17 (1.02–1.33) | .022 | 1.00 (0.84–1.20) | .984 |